We are live on ! Find out more
BCM

Beryl Capital Management Portfolio holdings

AUM $111M
1-Year Est. Return 205.39%
This Fund
S&P 500
This Quarter Est. Return
+39.2%
1 Year Est. Return
+205.39%
3 Year Est. Return
+3,931.93%
5 Year Est. Return
+11,104.4%
10 Year Est. Return
–
AUM
$620M
AUM Growth
+$233M
Cap. Flow
+$153M
Cap. Flow %
24.62%
Top 10 Hldgs %
73.77%
Holding
70
New
41
Increased
5
Reduced
–
Closed
22

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$67.8M
2
TIF
Tiffany & Co.
TIF
+$66.2M
3
MDCO
Medicines Co
MDCO
+$47.5M
4
INXN
Interxion Holding N.V.
INXN
+$37.9M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$29.8M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$91.5M
2
BPL
Buckeye Partners, L.P.
BPL
+$87.9M
3
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
+$26.4M
4
BID
Sotheby's
BID
+$22.6M
5
TYPE
Monotype Imaging Holdings Inc.
TYPE
+$20.5M

Sector Composition

Rank Sector Weight
1 Healthcare 42.55%
2 Consumer Discretionary 17.2%
3 Industrials 8.99%
4 Technology 7.62%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$78.5M 12.65%
410,424
+375,791
+1,085% +$67.8M
TIF
2
DELISTED
Tiffany & Co.
TIF
$74.8M 12.06%
+559,900
New +$66.2M
WCG
3
DELISTED
Wellcare Health Plans, Inc.
WCG
$66.2M 10.68%
200,606
+99,410
+98% +$29.8M
MDCO
4
DELISTED
Medicines Co
MDCO
$60.4M 9.74%
+711,667
New +$47.5M
INXN
5
DELISTED
Interxion Holding N.V.
INXN
$38M 6.12%
+453,433
New +$37.9M
BOLD
6
DELISTED
Audentes Therapeutics, Inc
BOLD
$32.9M 5.31%
+550,426
New +$20.7M
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
$29.3M 4.73%
2,156,018
+1,333,964
+162% +$16.9M
WAIR
8
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$27M 4.35%
+2,447,363
New +$26.9M
TECD
9
DELISTED
Tech Data Corp
TECD
$26.4M 4.25%
+183,527
New +$23.6M
ARQL
10
DELISTED
Arqule Inc
ARQL
$24.1M 3.89%
+1,208,101
New +$14M
TOO
11
DELISTED
Teekay Offshore Partners L.P.
TOO
$20.1M 3.23%
+13,024,380
New +$20M
PE
12
DELISTED
PARSLEY ENERGY INC
PE
$19.4M 3.12%
+1,024,925
New +$16.9M
CISN
13
DELISTED
Cision Ltd. Ordinary Share
CISN
$17.7M 2.85%
+1,776,448
New +$17M
TGE
14
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$17.4M 2.81%
+788,560
New +$15.1M
BMY.RT
15
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$17.2M 2.78%
+5,720,607
New +$14.9M
LTS
16
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$16.8M 2.71%
+4,823,765
New +$14M
EE
17
DELISTED
El Paso Electric Company
EE
$12M 1.94%
+177,081
New +$11.9M
AXE
18
DELISTED
Anixter International Inc
AXE
$5.16M 0.83%
+56,043
New +$4.54M
CLF icon
19
Cleveland-Cliffs
CLF
$6.63B
$4.73M 0.76%
+562,738
New +$4.32M
OMN
20
DELISTED
OMNOVA Solutions Inc.
OMN
$3.23M 0.52%
319,496
+60,068
+23% +$607K
LPT
21
DELISTED
Liberty Property Trust
LPT
$2.58M 0.42%
+42,947
New +$2.46M
INST
22
DELISTED
Instructure, Inc.
INST
$2.35M 0.38%
+48,744
New +$2.29M
WEBK
23
DELISTED
Wellesley Bancorp, Inc.
WEBK
$1.81M 0.29%
+40,000
New +$1.44M
THOR
24
DELISTED
Synthorx, Inc. Common Stock
THOR
$1.79M 0.29%
+25,653
New +$733K
UCFC
25
DELISTED
United Community Financial Corp
UCFC
$1.78M 0.29%
+152,813
New +$1.71M
1
2 3

Similar funds

WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
DI
Dalton Investments Las Vegas, Nevada $111M AUM 7.89% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM

Beryl Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Beryl Capital Management held 70 positions worth $620M, up 60% from $388M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Beryl Capital Management deployed $153M of net new capital in Q4 2019, opening 41 new positions and adding to 5 existing holdings. Its largest new stake was Tiffany & Co.: 559,900 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the most notable exit was Celgene Corp, an estimated $91.5M sold.

  • Beryl Capital Management's largest Q4 2019 buy was Tiffany & Co.: 559,900 shares worth $74.8M.
  • Beryl Capital Management added most to Allergan plc in Q4 2019, an estimated $67.8M increase.
  • Beryl Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $91.5M.
  • Beryl Capital Management's ten largest holdings make up 74% of its $620M portfolio in Q4 2019.
  • Beryl Capital Management opened 41 new positions and closed 22 in Q4 2019.
  • Beryl Capital Management's portfolio value rose 60% quarter-over-quarter to $620M.

Based on Beryl Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.